Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 15, 2008Clinical Cancer ResearchOpen Access

Translating an Antagonist of Chemokine Receptor CXCR4: From Bench to Bedside

View Full Paper
Ask AI
Bookmark
Share

Authors

DWDonald WongUniversity of Southern CaliforniaWKWalter KorzInimex Pharmaceuticals (Canada)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wong et al. (2008) studied this question.

synapsesocial.com/papers/6a006219b124fe581985dbefhttps://doi.org/10.1158/1078-0432.ccr-07-4846
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bioluminescence Resonance Energy Transfer Reveals Ligand-induced Conformational Changes in CXCR4 Homo- and Heterodimers2005 · 262 citations
  2. 2The chemokine SDF‐lα triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway1999 · 506 citations
  3. 3Differential Functional Activation of Chemokine Receptor CXCR4 Is Mediated by G Proteins in Breast Cancer Cells2006 · 112 citations
  4. 4The α-Chemokine, Stromal Cell-derived Factor-1α, Binds to the Transmembrane G-protein-coupled CXCR-4 Receptor and Activates Multiple Signal Transduction Pathways1998 · 622 citations
  5. 5CXCL12/CXCR4 signaling activates Akt‐1 and MMP‐9 expression in prostate cancer cells: The role of bone microenvironment‐associated CXCL122005 · 246 citations